Literature DB >> 14636254

Mast cell chymase expression in Helicobacter pylori-associated gastritis.

T Matsuo1, Y Ikura, M Ohsawa, M Ogami, S Kayo, N Yoshimi, E Hai, T Naruko, M Ohishi, K Higuchi, T Arakawa, M Ueda.   

Abstract

AIMS: To study the role of mast cell chymase in the inflammatory processes of human chronic gastritis. Experimental studies have shown that mast cell chymase stimulates inflammatory cell accumulation, and contributes to angiotensin II formation. METHODS AND
RESULTS: Tissue sections from human stomachs with Helicobacter pylori-associated gastritis (surgery/autopsy n = 20; biopsy n = 16) and normal stomachs (n = 10) were studied using immunohistochemical single and double labelling techniques. Monoclonal antibodies used were directed against mast cell chymase, tryptase, neutrophils (CD66b, elastase, and myeloperoxidase), macrophages, T-lymphocytes, and interleukin (IL)-4. The expression of angiotensin-converting enzyme and angiotensin II type 1 receptor was investigated using immunohistochemical analysis and the reverse transcription-polymerase chain reaction. The number of chymase-positive mast cells was significantly higher (P < 0.0001) in H. pylori-associated gastritis than in normal stomachs. Increased expression of chymase in inflamed mucosa was closely related to an increase in the accumulation of neutrophils, macrophages, T-lymphocytes, and IL-4-positive cells. The expression of angiotensin-converting enzyme and angiotensin II type 1 receptor was not altered in gastritis specimens.
CONCLUSIONS: These observations suggest that mast cell chymase may be an important mediator in the inflammatory processes of human H. pylori-associated gastritis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14636254     DOI: 10.1111/j.1365-2559.2003.01731.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  7 in total

1.  Phenotypic change and accumulation of smooth muscle cells in strictures in Crohn's disease: relevance to local angiotensin II system.

Authors:  Takehisa Suekane; Yoshihiro Ikura; Kenji Watanabe; Junko Arimoto; Yoko Iwasa; Yoshimi Sugama; Soichiro Kayo; Kenichi Sugioka; Takahiko Naruko; Kiyoshi Maeda; Kosei Hirakawa; Tetsuo Arakawa; Makiko Ueda
Journal:  J Gastroenterol       Date:  2010-04-02       Impact factor: 7.527

2.  Expression of angiotensin II type 1 and type 2 receptor mRNAs in the gastric mucosa of Helicobacter pylori-infected Mongolian gerbils.

Authors:  Mitsushige Sugimoto; Tomoyuki Ohno; Yoshio Yamaoka
Journal:  J Gastroenterol       Date:  2011-07-13       Impact factor: 7.527

Review 3.  Physiological and pathophysiological functions of intestinal mast cells.

Authors:  Stephan C Bischoff
Journal:  Semin Immunopathol       Date:  2009-06-17       Impact factor: 9.623

4.  Involvement of mast cells in gastritis caused by Helicobacter pylori: a potential role in epithelial cell apoptosis.

Authors:  Véronique Hofman; Sandra Lassalle; Eric Selva; Kheira Kalem; Adrien Steff; Xavier Hébuterne; Dominique Sicard; Patrick Auberger; Paul Hofman
Journal:  J Clin Pathol       Date:  2007-06       Impact factor: 3.411

5.  Angiotensin II receptor expression and relation to Helicobacter pylori-infection in the stomach of the Mongolian gerbil.

Authors:  Peter Hallersund; Herbert F Helander; Anna Casselbrant; Anders Edebo; Lars Fändriks; Anders Elfvin
Journal:  BMC Gastroenterol       Date:  2010-01-14       Impact factor: 3.067

6.  IL-9- and mast cell-mediated intestinal permeability predisposes to oral antigen hypersensitivity.

Authors:  Elizabeth E Forbes; Katherine Groschwitz; J Pablo Abonia; Eric B Brandt; Elizabeth Cohen; Carine Blanchard; Richard Ahrens; Luqman Seidu; Andrew McKenzie; Richard Strait; Fred D Finkelman; Paul S Foster; Klaus I Matthaei; Marc E Rothenberg; Simon P Hogan
Journal:  J Exp Med       Date:  2008-03-31       Impact factor: 14.307

7.  The FLS (fatty liver Shionogi) mouse reveals local expressions of lipocalin-2, CXCL1 and CXCL9 in the liver with non-alcoholic steatohepatitis.

Authors:  Toshihisa Semba; Motoi Nishimura; Satomi Nishimura; Osamu Ohara; Takayuki Ishige; Sayaka Ohno; Ken Nonaka; Kazuyuki Sogawa; Mamoru Satoh; Setsu Sawai; Kazuyuki Matsushita; Fumio Imazeki; Osamu Yokosuka; Fumio Nomura
Journal:  BMC Gastroenterol       Date:  2013-07-23       Impact factor: 3.067

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.